Form 4: 180 Life Sciences Director Acquires 65,000 Shares of Common Stock

Jay Lawrence Goodman, a director of 180 Life Sciences Corp., acquired 65,000 shares of common stock as compensation for services rendered.

Summary

• On February 20, 2025, Jay Lawrence Goodman, a director of 180 Life Sciences Corp., acquired 65,000 shares of common stock.
• The shares were issued as compensation for services rendered as a member of the Board of Directors.
• The shares were issued under the Issuer's 2022 Equity Compensation Plan.
• The restricted stock shares are subject to time-based vesting, with 1/2 vesting on July 1, 2025, and the remaining 1/2 vesting on December 31, 2025, contingent upon continued service to the Issuer.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a director's increased stake in the company, aligning their interests with shareholders. The vesting schedule further reinforces commitment.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The vesting schedule incentivizes continued service and commitment from the director.

Future Outlook

The director's continued service is tied to the vesting of the shares, suggesting an ongoing commitment to the company.

Industry Context

Director share acquisitions are common and often viewed positively, signaling confidence in the company's prospects. Equity compensation is a standard practice for aligning management and shareholder interests.

Stakeholder Impact

• Shareholders may view the director's share acquisition positively, as it aligns management's interests with their own.
• The vesting schedule incentivizes the director to contribute to the company's success.

Key Dates

Keywords

180 Life Sciences Corp, Director, Share Acquisition, Form 4, Equity Compensation, Jay Lawrence Goodman, ATNF, Vesting